Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.
McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT.
McComsey GA, et al. Among authors: moser c.
Clin Infect Dis. 2016 Apr 1;62(7):853-62. doi: 10.1093/cid/ciw017. Epub 2016 Jan 20.
Clin Infect Dis. 2016.
PMID: 26797215
Free PMC article.
Clinical Trial.